Markets
TIF

U.S. Stock Futures Follow European Markets Higher on Hopes for Greece Deal

U.S. stock futures took their cue from European markets Friday on optimism for a Greece-funding deal.

The Friday climb follows an up-then-down run in the wake of the Federal Reserve's Wednesday signal that it won't be so quick to raise interest rates.

In Europe, a joint statement by Greece and European Union counterparts said Greece will submit a "full list of specific reforms" in the next few days and Greek Prime Minister Alexis Tsipras said he was optimistic the European Union will work to restore funding as soon as possible.

Still to come, at 10:20 a.m. ET, Atlanta Federal Reserve Bank President Dennis Lockhart is scheduled to speak on the economy and monetary policy. At 11:30 a.m., Chicago Fed President Charles Evans will be on a panel discussing risk management in Washington.

In equities, jeweler Tiffany & Co.'s ( TIF ) shares fell 3.2% in recent pre-market trading after warning of minimal growth in 2015 as the strong dollar weighs on translating overseas sales. Meanwhile, Biogen Idec ( BIIB ) shares surged 8.9% after the biotechnology company said an interim study showed reduction in amyloid plaque in Alzheimer's patients. Amyloid plaque is believed to play a key role in the development of symptoms of the disease.

U.S. PRE-MARKET INDICATORS

-Dow Jones Industrial up 0.9%

-S&P 500 futures up 0.7%

-Nasdaq 100 futures up 0.8%

-Nasdaq 100 pre-market indicator up 0.6%

GLOBAL SENTIMENT

Nikkei up 0.4%

Hang Seng down 0.4%

Shanghai Composite up 1.4%

FTSE-100 up 0.3%

DAX-30 up 1.2%

PRE-MARKET SECTOR WATCH

(+/-) Large cap tech: mixed

(+/-) Chip stocks: mixed

(+) Software stocks: unchanged to higher

(+/-) Hardware stocks: mixed

(+) Internet stocks: higher

(+) Drug stocks: higher

(+) Financial stocks: higher

(+) Retail stocks: unchanged to higher

(+) Industrial stocks: higher

(+) Airlines: higher

(+) Autos: higher

UPSIDE MOVERS

(+) CTRP (+19.9%) Reports narrower Q4 loss; sees Q1 revenue up 40%-50%

(+) NKE (+5.2%) Fiscal Q3 beats views; Janney Capital raises PT

(+) SPEX (+23.4%) Reports 'important milestone; in patent infringement litigation

(+) VGGL (+29.7%) CEO wants to buy 25% of co's Wetpant business for $10 million in cash

(+) PRTA (+38.6%) Meets primary endpoint in Parkinson's disease drug study

(+) DRI (+4.3%) Fiscal Q3, Q4 guidance beats views

(+) ICPT (+8.1%) Presents data from obeticholic acid study

(+) CMCM (+3.6%) Q4 sales top estimates

(+) PIR (-5.2%) Oppenheimer upgrades to outperform vs market perform

(+) OC (+2.5%) Barclays upgrades to overweight vs equal weight

(+) JKS (+2.8%) Collaborates with DuPont to advance solar energy

(+) STM (+2.8%) Morgan Stanley upgrades to equal weight vs underweight

(+) HON (+1.7%) Goldman Sachs upgrades to conviction buy

(+) GFF (+0.8%) OKs another $50 million for stock buybacks

DOWNSIDE MOVERS

(-) MAC (-7.7%) SPG (+1.0%) makes best & final offer of $95 per share

(-) THRX (-6.3%) FDA committee doesn't recommend approval of asthma drug in patients between 12-17 years; calls for large trials

(-) YOKU (-3.0%) Q4 net loss widens; Brean Capital cuts PT

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

TIF BIIB

Other Topics

Commodities

Latest Markets Videos